Articles Archives - Page 239 of 714

MondayJul 25, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Completes Acquisition of Largest-Ever DMT Study

Data from newly acquired study could accelerate clinical development of CYBN’s CYB004 by nine months The pivotal study was designed with four primary objectives Cybin’s proprietary substance has potential to effectively treat anxiety disorders, including GAD and SAD Cybin (NEO: CYBN) (NYSE American: CYBN) has completed the acquisition of the largest dimethyltryptamine (“DMT”) study to date, a Phase 1 N,N-DMT study that provides key data relating to the company’s proprietary CYB004 substance (https://ibn.fm/2Ab0T). Information from the study is expected to help the company accelerate by up to nine months its clinical development pathway of CYB004. “With the closing of this transaction…

FridayJul 22, 2022 10:00 am

Looking for an Edge? Golden Matrix Group Inc. (NASDAQ: GMGI) to Release Peer-to-Peer Esports Betting Product

GMGI CEO says new P2P Esports offering coming “quite soon” Gaming operators have need for new products to grow market share New product overcomes challenges related to compliance in Esports gambling If you’re paying attention to the sports betting market, you’re seeing companies big and small looking for edges to capture market share from competition in a fierce, albeit huge, marketplace. It’s tough to carve out profits when, in the words of Brian Goodman, CEO of Golden Matrix Group (NASDAQ: GMGI), “everyone [is] fishing in the same pond.” Companies must be differentiated, as is Golden Matrix, a provider of turnkey…

FridayJul 22, 2022 9:45 am

Industry Experts to Share Invaluable Insights at the Premier EV Charging Conference in August 2022

The EV Charging Conference 2022 is a 2-day virtual event designed to optimize education, learning, and networking among industry professionals in the electric vehicle market and other participants. The highly specialized event focuses on addressing fundamentals at residential and commercial levels to drive ROI across the EV landscape and clean energy. Key Details The push for NetZero is creating a massive, untapped opportunity for EV Charging Reinvent your electric strategy for residential or commercial properties Thought leaders will share their knowledge, skills, and expertise to enable the successful integration of profitable EV charging into your organization The forthcoming EV Charging…

FridayJul 22, 2022 9:00 am

Successful Early Testing of Concussion Therapy Drives Optimism for Odyssey Health, Inc. (ODYY) as Next-stage Trials are Readied

Medical technology innovator Odyssey Health Inc. is using clinical tests to establish the safety of a therapy designed to treat concussion injuries in its earliest moments The company is enthused by results from the early-stage testing and is preparing to design a Phase II/III trial that will target efficacy results in volunteer subjects, focusing particularly on members of the military Odyssey’s technology combines a synthetic medication with a specially designed application device that helps the medication cross the blood-brain barrier for immediate responsiveness following a mild traumatic brain injury (“mTBI”) Medication for concussion treatment remains an unmet need and Odyssey…

ThursdayJul 21, 2022 11:15 am

Mullen Automotive Inc. (NASDAQ: MULN) Recently Featured on Benzinga, Noting Solid-State Battery Test Results that Exceed Expectations, Extend EV Range

MULN shares traded higher after Benzinga stated that the emerging EV manufacturer had reported higher-than-expected battery test results Data shows the company’s proprietary solid-state polymer batteries can deliver more than 600 miles of range on a full charge The company plans to include the new batteries in its second-generation Mullen FIVE EV Crossover Mullen Automotive (NASDAQ: MULN) was featured in a recent Benzinga Brief. The short summary noted that the company, an emerging electric-vehicle manufacturer, had reported results of its solid-state polymer battery testing, which exceeded expectations (https://ibn.fm/XI6Fa). Noting that shares were trading higher after the news, Benzinga quoted David…

ThursdayJul 21, 2022 9:45 am

Correlate Infrastructure Partners Inc. (CIPI) Helping to Lay Down a Roadmap for Widespread Clean Energy Adoption

Fossil fuels still account for about 80% of primary energy worldwide. They are responsible, on a per capita basis, for 63,130kWh of energy in the United States, with renewables only accounting for 8,266 kWh The United States, prior to the recent ban, had 8% of its total petroleum imports (including crude oil) coming from Russia, a reliance that has now resulted in significant increases in gasoline and diesel prices Correlate, through its distributed clean energy solutions, is addressing these issues, helping to bring society closer to significantly less dependence on the national grid and more on green energy sources The…

ThursdayJul 21, 2022 9:00 am

With Fertilizer Prices, Climate Change, and Low Crop Yields Threatening the Rice Industry, FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) May Have a Relevant Zero Carbon Emission Solutions

The rice production industry is under an imminent threat due to increased demand and reduced crop yields With Thailand, the Philippines, and China all facing problems in rice production, a lot rides on the success of India’s rice crops, despite the uncertainty of monsoon and harvest season FuelPositive Corp. is currently developing proprietary green ammonia technology driving for on-site fertilizer production and zero carbon emissions The rice production industry faces multiple imminent threats worldwide, including rising fertilizer costs, climate change, and increased demand when crop yields seem to be declining. These threats pose a potential risk to food security and…

WednesdayJul 20, 2022 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pending Start of Human Nicotine Study, NIC-H22-1, Leveraging Fast-Growing Global Nicotine Pouches Market

Lexaria Bioscience Corp. expects the upcoming human nicotine study to produce evidence that its patented DehydraTECH(TM) technology can enhance oral-tissue absorption with reduced negative experiences Data collected from animal study NIC-A21-1 showed that DehydraTECH enhanced oral nicotine pouches delivered peak nicotine levels in the bloodstream of animals 10x to 20x faster than the control The global nicotine pouches market was valued at $2.33 billion in 2020 and is expected to reach $21.84 billion by 2027, being one of the fastest growing segments in the nicotine industry Lexaria's pipeline addresses serious unmet patient or consumer needs with greater market potential, addressing…

WednesdayJul 20, 2022 9:45 am

Nowigence Inc. (NOWG) Makes Inroads in India, Announces Independent Growth Council

NOWG signs MOU creating a strategic business partnership that will deliver value in India’s growing CSR market India has made CSR obligatory, requiring top companies that meet specific requirements to spend 2% of their normal net benefits on CSR initiatives annually The company announces the creation of the Nowigence Independent Growth Council As evidence of its continued commitment to and progress toward becoming a gamechanger in the global data gathering and analysis space, Nowigence (OTCQB: NOWG) has made two key announcements. First, Nowigence signed a memorandum of understanding (“MOU”) with India-based EquiPPP Social Impact Technologies Ltd. (https://ibn.fm/NiyLD). Second, Nowigence has…

WednesdayJul 20, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Responds to Growing Concerns About Concussion Head Injuries with Drug Device in Clinical Trial

As awareness of the long-term hazards of concussive head injuries for young athletes has increased during the past decade, advocates and business enterprises have stepped up to improve coach responsiveness to players’ condition While efforts primarily focus on assessing injury, Odyssey Health Inc. is developing a product it hopes to become the first drug device with FDA approval for treating a concussed patient after injury Odyssey is enrolling patients in a Phase 1 human clinical trial after completing pre-clinical studies in laboratory animals The medical research company’s assets include treatments for patients who may have undiagnosed heart disease, patients choking…

Site Search

Company Search

Category: Articles